Ambulatory GFR measurement with cold iothalamate in adults with chronic kidney disease

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Background: The purpose of this study is to develop a method that eliminates the use of radioactive agents, reduces the length of inpatient visits, and does not require urine collection for the measurement of glomerular filtration rate (GFR) in adults with chronic kidney diseases (CKD). Methods: We measured simultaneous urinary and plasma clearance of iothalamate using high-performance liquid chromatography in 30 patients with CKD after a continuous subcutaneous infusion of iothalamate at a rate of 125 μL/h for a 24-hour period. To ascertain whether a steady state was achieved with a 24-hour infusion, in 20 additional patients, we infused iothalamate continuously for 48 hours and measured GFR after 24 and 48 hours. Results: Plasma iothalamate levels and urinary excretion rates obtained after 24- and 48-hour infusions were similar. GFR estimated by plasma clearance (44.4 mL/min; 95% confidence interval [Cl], 37.0 to 53.3) was similar to urinary clearance (41.6 mL/min; 95% Cl, 34.7 to 50.0) and without bias (average difference, 7%; 95% Cl, + 18% to -38%; P = 0.866). There also was acceptable agreement between plasma and urinary clearance of iothalamate (coefficient of variation [CV], 19.6% between techniques). Reproducibility of day-to-day plasma continuous infusion clearance technique was less than 12%. There was good agreement (CV, 19.9%) between inulin and renal iothalamate clearances. Conclusion: These data show that ambulatory infusion of iothalamate can be used to measure GFR in adults with CKD without the need for urine collections with acceptable precision and without exposure to radioactivity.

Original languageEnglish
Pages (from-to)752-759
Number of pages8
JournalAmerican Journal of Kidney Diseases
Volume41
Issue number4
StatePublished - Apr 1 2003

Fingerprint

Iothalamic Acid
Glomerular Filtration Rate
Chronic Renal Insufficiency
Urine Specimen Collection
Subcutaneous Infusions
Inulin
Radioactivity
Inpatients
High Pressure Liquid Chromatography
Confidence Intervals
Kidney

Keywords

  • Chronic kidney disease (CKD)
  • Glomerular filtration rate (GFR)
  • Iothalamate

ASJC Scopus subject areas

  • Nephrology

Cite this

Ambulatory GFR measurement with cold iothalamate in adults with chronic kidney disease. / Agarwal, Rajiv.

In: American Journal of Kidney Diseases, Vol. 41, No. 4, 01.04.2003, p. 752-759.

Research output: Contribution to journalArticle

@article{1be5fdb8966e4352baa1cb2bd2e2a33c,
title = "Ambulatory GFR measurement with cold iothalamate in adults with chronic kidney disease",
abstract = "Background: The purpose of this study is to develop a method that eliminates the use of radioactive agents, reduces the length of inpatient visits, and does not require urine collection for the measurement of glomerular filtration rate (GFR) in adults with chronic kidney diseases (CKD). Methods: We measured simultaneous urinary and plasma clearance of iothalamate using high-performance liquid chromatography in 30 patients with CKD after a continuous subcutaneous infusion of iothalamate at a rate of 125 μL/h for a 24-hour period. To ascertain whether a steady state was achieved with a 24-hour infusion, in 20 additional patients, we infused iothalamate continuously for 48 hours and measured GFR after 24 and 48 hours. Results: Plasma iothalamate levels and urinary excretion rates obtained after 24- and 48-hour infusions were similar. GFR estimated by plasma clearance (44.4 mL/min; 95{\%} confidence interval [Cl], 37.0 to 53.3) was similar to urinary clearance (41.6 mL/min; 95{\%} Cl, 34.7 to 50.0) and without bias (average difference, 7{\%}; 95{\%} Cl, + 18{\%} to -38{\%}; P = 0.866). There also was acceptable agreement between plasma and urinary clearance of iothalamate (coefficient of variation [CV], 19.6{\%} between techniques). Reproducibility of day-to-day plasma continuous infusion clearance technique was less than 12{\%}. There was good agreement (CV, 19.9{\%}) between inulin and renal iothalamate clearances. Conclusion: These data show that ambulatory infusion of iothalamate can be used to measure GFR in adults with CKD without the need for urine collections with acceptable precision and without exposure to radioactivity.",
keywords = "Chronic kidney disease (CKD), Glomerular filtration rate (GFR), Iothalamate",
author = "Rajiv Agarwal",
year = "2003",
month = "4",
day = "1",
language = "English",
volume = "41",
pages = "752--759",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Ambulatory GFR measurement with cold iothalamate in adults with chronic kidney disease

AU - Agarwal, Rajiv

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Background: The purpose of this study is to develop a method that eliminates the use of radioactive agents, reduces the length of inpatient visits, and does not require urine collection for the measurement of glomerular filtration rate (GFR) in adults with chronic kidney diseases (CKD). Methods: We measured simultaneous urinary and plasma clearance of iothalamate using high-performance liquid chromatography in 30 patients with CKD after a continuous subcutaneous infusion of iothalamate at a rate of 125 μL/h for a 24-hour period. To ascertain whether a steady state was achieved with a 24-hour infusion, in 20 additional patients, we infused iothalamate continuously for 48 hours and measured GFR after 24 and 48 hours. Results: Plasma iothalamate levels and urinary excretion rates obtained after 24- and 48-hour infusions were similar. GFR estimated by plasma clearance (44.4 mL/min; 95% confidence interval [Cl], 37.0 to 53.3) was similar to urinary clearance (41.6 mL/min; 95% Cl, 34.7 to 50.0) and without bias (average difference, 7%; 95% Cl, + 18% to -38%; P = 0.866). There also was acceptable agreement between plasma and urinary clearance of iothalamate (coefficient of variation [CV], 19.6% between techniques). Reproducibility of day-to-day plasma continuous infusion clearance technique was less than 12%. There was good agreement (CV, 19.9%) between inulin and renal iothalamate clearances. Conclusion: These data show that ambulatory infusion of iothalamate can be used to measure GFR in adults with CKD without the need for urine collections with acceptable precision and without exposure to radioactivity.

AB - Background: The purpose of this study is to develop a method that eliminates the use of radioactive agents, reduces the length of inpatient visits, and does not require urine collection for the measurement of glomerular filtration rate (GFR) in adults with chronic kidney diseases (CKD). Methods: We measured simultaneous urinary and plasma clearance of iothalamate using high-performance liquid chromatography in 30 patients with CKD after a continuous subcutaneous infusion of iothalamate at a rate of 125 μL/h for a 24-hour period. To ascertain whether a steady state was achieved with a 24-hour infusion, in 20 additional patients, we infused iothalamate continuously for 48 hours and measured GFR after 24 and 48 hours. Results: Plasma iothalamate levels and urinary excretion rates obtained after 24- and 48-hour infusions were similar. GFR estimated by plasma clearance (44.4 mL/min; 95% confidence interval [Cl], 37.0 to 53.3) was similar to urinary clearance (41.6 mL/min; 95% Cl, 34.7 to 50.0) and without bias (average difference, 7%; 95% Cl, + 18% to -38%; P = 0.866). There also was acceptable agreement between plasma and urinary clearance of iothalamate (coefficient of variation [CV], 19.6% between techniques). Reproducibility of day-to-day plasma continuous infusion clearance technique was less than 12%. There was good agreement (CV, 19.9%) between inulin and renal iothalamate clearances. Conclusion: These data show that ambulatory infusion of iothalamate can be used to measure GFR in adults with CKD without the need for urine collections with acceptable precision and without exposure to radioactivity.

KW - Chronic kidney disease (CKD)

KW - Glomerular filtration rate (GFR)

KW - Iothalamate

UR - http://www.scopus.com/inward/record.url?scp=0037382244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037382244&partnerID=8YFLogxK

M3 - Article

C2 - 12666061

AN - SCOPUS:0037382244

VL - 41

SP - 752

EP - 759

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 4

ER -